Navigation Links
MacroGenics Appoints New Chief Commercial Officer and Chief Financial Officer
Date:5/6/2008

ROCKVILLE, Md., May 6 /PRNewswire/ -- MacroGenics Inc, a private biotechnology company focused on the development of products to treat autoimmune disorders, cancers, and infectious diseases, today announced the appointments of Dr. Jean-Christophe Tellier as Executive Vice President and Chief Commercial Officer and Mr. James Karrels as Vice President and Chief Financial Officer. "We are very fortunate to attract two exceptionally talented professionals to the executive management team at MacroGenics," said Dr. Scott Koenig, President and CEO. "Both Jean-Christophe and Jim exhibit personal qualities and experiences that are among the best in the biotechnology and pharmaceutical industry, and they will complement the skills of our already extraordinary management group, as we position our company for growth and advance our pipeline towards commercialization."

Dr. Tellier joins MacroGenics after a distinguished 20 year career in commercial development at Novartis. Since February 2007, he served as Chairman and CEO of Novartis Pharma France and Novartis Group France. The Group comprises 2,800 employees with sales at Novartis Pharma France of about 1 billion, including marketed brand name products in cardiovascular, oncology, neurosciences, respiratory, dermatology, transplant/immunology, infectious diseases, and ophthalmology. Prior to this, Dr. Tellier was Head of the Global Business Franchise for Arthritis, Bone, and Muscle Disease headquartered in Basel. From January 2003 through September 2006, Dr. Tellier served as CEO of Novartis Pharma Belgium and Country President where he was responsible for all business units and support services and coordination of all product sectors including OTC, generics, and Ciba Vision. During this tenure, he became President of the Board of the Belgian Pharma Trade association (Pharma.be), the first non-Belgium citizen to be elected to this position. Dr. Tellier received his MD from the University of Reims Champagne- Arden
'/>"/>

SOURCE MacroGenics Inc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
2. WorldHeart Appoints David Pellone Chief Financial Officer
3. Novo Nordisk Appoints New Leader of North American Business
4. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. Resonant Medical Appoints New Vice President of Global Sales
7. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
8. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
9. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
10. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
11. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...on an emotional rollercoaster, study finds , ...it the fear factor meets the jubilant sports fan. ...ially those who root for the winning team -- enjoy...sted match and victory was in doubt, producing fee... this Thanksgiving weekend as you,re glued to the ...
(Date:11/26/2009)...David Kim of the Live Life Again Center, a practic... of a growing number of physicians who are taking...onnect with individuals who are interested in surg.... Dr. Kim is utilizing Facebook to share before-an...with the community. , Dal...
(Date:11/26/2009)...on Communications announces a highly effective and...rs struggling to make an economic recovery. , ...Flu fears is the type of challenge that could send...ding to Dr. David Benton, business growth expert a...stem – The Rfactor Intensive . “Fea...
(Date:11/25/2009)... 25 When most people he...But a chiropractor can also give patients the help... Joint, which is where your jaw (mandible) contact... The most common symptoms associated with TMJ dysf... of the jaw. But many other symptoms can be cause...
(Date:11/25/2009)...f., Nov. 25 Onyx Pharm...that the company will host two investor events in ... 7, 2009 - 9:00 a.m. CT/10:00 a.m. ET ,, Prin...s surrounding carfilzomib in relapsed and/or refra...erican Society of Hematology (ASH) Annual Meeting ...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...e the way to new methods for studying and finding ...of death in industrialized countries, according to...at mutations in a molecular channel found in heart...rolled in the cell could lead to new heart disease...
...rprises. They don't scrape and poke. They massage ... prescribe homeopathic remedies//. Of course...nded colleagues sceptical. Sometimes, there's only...ral Medicine Dentists. The important steps come be...
... higher than national guidelines recommend that, i...ening//, according to a study published in the iss...rican Academy of Neurology. The study of 1,...ines. TIA happens when blood flow to part of the b...
...the risk of becoming infected with tuberculosis (T...B disease//, according to an analysis of previousl...ine. About one-third of the world’s populatio...und information in the article. Active tuberculosi...
...nib, marketed by London company AstraZeneca PLC// ... of lung cancer in whom the first-line treatment h... 20 sites. The patients who have a recorded a... line treatment. Says Medical Science Director...
...d with a brain tumor which is at the stem of her b...to approach the doctor who after routine tests rev...ble brain tumor. The doctors have given her three ...r. According to the doctors, there is a 20 % chanc...
Other Medicine News:Health News:Fruit Flies May Pave Way to New Treatments for Age-related Heart Disease 2Health News:Fruit Flies May Pave Way to New Treatments for Age-related Heart Disease 3Health News:Homeopathy and Hypnosis Come to Dentistry 2Health News:Cholesterol in Stroke Patients Exceeds National Guidelines 2Health News:Susceptibility to TB is High Among the Smokers 2
(Date:11/25/2009)..., WEST PALM BEACH, Fla., Nov. 25 /PRNewswire-First...red Americans, especially the 27 million living wi...be all that happy, says audiologist Cindy Beyer. ,...Amex: EAR ), one of America,s largest hearing car...linked hearing loss to stress, frustration, and so...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportlink... is available in its catalogue: ,, United Stat... 2015 ,, http://www.reportlinker.com/p0158733...Forecasts-to-2015.html ,, United States Dental..., Summary ,, This report is an essential sou...
(Date:11/25/2009)... , SAN DIEGO, Nov. 25 /PRNewswire-FirstCall/ ...ce company focused on developing products for mini..., announced today that it will host a conference c.../ 2:30 p.m. PT. The conference call will focus on...Company,s products and will include comments from ...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4 2415 million stimulus award creates national consortium for revealing scientific resources 10601 1 2415 million stimulus award creates national consortium for revealing scientific resources 10601 2 2415 million stimulus award creates national consortium for revealing scientific resources 10601 3Developmental drug may help bone fractures heal after radiation exposure 60527 1Delays in Lung Cancer Care More Common in Public Hospitals 60523 1
...studies presented at the National Lipid ...RSIPPANY, N.J., May 30 Daiichi Sankyo, Inc.,annou...ee pivotal studies,demonstrated that the addition ...es treatment regimens can lower A1C in patients wi...analyses included all patients receiving,Welchol i...
...N,PHARMACEUTICALS, INC. (Nasdaq: VION ) today ann...ead anticancer agent Cloretazine(R) (VNP40101M) in...ed in posters at the 2008,American Society of Clin...Illinois., The poster (Abstract #7051) entitled "... III study of high-dose continuous infusion cytosi...
Other Medicine Technology:Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 2Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 3Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 4Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 5Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 6Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting 2Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting 3
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
Medicine Products: